Six novel minimally invasive therapies for benign prostatic hyperplasia.
10.3724/zdxbyxb-2022-0593
- Author:
Xinyang NIU
1
;
Ben LIU
2
Author Information
1. Department of Urology, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China. niuxy17@zju.edu.cn.
2. Department of Urology, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China. drliuben@zju.edu.cn.
- Publication Type:Journal Article
- Keywords:
Aquablation-image guided robotic waterjet ablation;
Benign prostatic hyperplasia;
Minimally invasive therapies;
Prostatic artery embolisation;
Prostatic stents;
Prostatic urethral lift;
Review;
Temporary implantable nitinol device;
Water vapor thermal therapy
- MeSH:
Male;
Humans;
Prostatic Hyperplasia/complications*;
Stents/adverse effects*;
Embolization, Therapeutic/adverse effects*;
Lower Urinary Tract Symptoms/surgery*;
Treatment Outcome;
Minimally Invasive Surgical Procedures
- From:
Journal of Zhejiang University. Medical sciences
2023;52(2):162-168
- CountryChina
- Language:English
-
Abstract:
Benign prostatic hyperplasia (BPH) is the most common cause of lower urinary tract symptoms in men. When drug treatment is ineffective or conventional surgery is not suitable, novel minimally invasive therapies can be considered. These include prostatic urethral lift, prostatic artery embolisation, water vapor thermal therapy, Aquablation-image guided robotic waterjet ablation, temporary implantable nitinol device and prostatic stents. These novel therapies can be performed in outpatient setting under local anesthesia, with shorter operative and recovery times, and better protection of ejaculatory function and erectile function. General conditions of the patient and advantages and disadvantages of the each of these therapies should be fully considered to make individualized plans.
